1932

Abstract

Recent advances in cell isolation techniques have greatly enhanced our understanding of the phenotype and function of hematopoietic stem cells in mice and humans. Many clinical studies have established the efficacy of using peripheral blood stem cells to supplement or replace bone marrow transplantation as a therapeutic modality for several types of malignancies. This new approach to malignant disease management, perhaps in combination with posttransplantation cytokine therapy, promises to completely alter the clinical course of bone marrow transplantation.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.45.1.93
1994-02-01
2024-04-19
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.45.1.93
Loading
/content/journals/10.1146/annurev.med.45.1.93
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error